Point72 Asset Management
PMVP icon

Point72 Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History

Point72 Asset Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,945
Closed -$26K – 4460
2026
Q1 		$26K Sell
20,945
-7,799
-27% -$9.92K ﹤0.01% 3680
2025
Q4 		$35.9K Buy
+28,744
New +$38.5K ﹤0.01% 3805
2024
Q2 		– Sell
-205,855
Closed -$350K – 2324
2024
Q1 		$350K Sell
205,855
-544,298
-73% -$1.02M ﹤0.01% 1738
2023
Q4 		$2.33M Buy
+750,153
New +$1.99M 0.01% 1152
2023
Q2 		– Sell
-38,178
Closed -$182K – 2654
2023
Q1 		$182K Buy
+38,178
New +$269K ﹤0.01% 1509

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Point72 Asset Management's PMVP Position: Q2 2026 in Review

Point72 Asset Management sold out of PMV Pharmaceuticals (PMVP) in Q2 2026, closing a stake of 20,945 shares — an estimated $26K sold.

Point72 Asset Management first reported a position in PMVP in Q1 2023 and held it in 5 quarters. The position peaked at $2.33M in Q4 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Point72 Asset Management reported no remaining PMV Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 20,945 PMV Pharmaceuticals shares in Q2 2026, an estimated $26K.
  • Point72 Asset Management first reported a position in PMV Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Point72 Asset Management's PMV Pharmaceuticals position peaked at $2.33M in Q4 2023.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.